Citigroup Inc Replimune Group, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Citigroup Inc holds 45,722 shares of REPL stock, worth $584,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,722

Previous 19,863 130.19%

Holding current value

$584,784

Previous $178,000 181.46%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.09 - $11.23 $209,199 - $290,396	25,859 Added 130.19%	45,722 $501,000
Q2 2024 Aug 12, 2024	SELL	$5.01 - $9.46 $2.62 Million - $4.94 Million	-522,626 Reduced 96.34%	19,863 $178,000
Q1 2024 May 10, 2024	BUY	$6.87 - $9.31 $2.47 Million - $3.34 Million	359,228 Added 196.02%	542,489 $4.43 Million
Q4 2023 Feb 09, 2024	BUY	$6.75 - $16.18 $700,204 - $1.68 Million	103,734 Added 130.44%	183,261 $1.54 Million
Q3 2023 Nov 09, 2023	BUY	$15.96 - $22.18 $415,901 - $577,988	26,059 Added 48.74%	79,527 $1.36 Million
Q2 2023 Aug 10, 2023	SELL	$15.65 - $24.1 $1.89 Million - $2.9 Million	-120,508 Reduced 69.27%	53,468 $1.24 Million
Q1 2023 May 11, 2023	BUY	$17.48 - $29.09 $2.44 Million - $4.07 Million	139,797 Added 409.01%	173,976 $3.07 Million
Q4 2022 Feb 09, 2023	SELL	$17.09 - $27.91 $612,761 - $1 Million	-35,855 Reduced 51.2%	34,179 $929,000
Q3 2022 Nov 10, 2022	BUY	$15.6 - $21.15 $154,861 - $209,956	9,927 Added 16.52%	70,034 $1.21 Million
Q2 2022 Aug 10, 2022	BUY	$13.32 - $19.98 $560,092 - $840,139	42,049 Added 232.86%	60,107 $1.05 Million
Q1 2022 May 12, 2022	SELL	$15.24 - $29.75 $642,853 - $1.25 Million	-42,182 Reduced 70.02%	18,058 $307,000
Q4 2021 Feb 10, 2022	BUY	$25.43 - $34.25 $368,531 - $496,351	14,492 Added 31.68%	60,240 $1.63 Million
Q3 2021 Nov 10, 2021	BUY	$28.98 - $39.54 $1.33 Million - $1.81 Million	45,748 New	45,748 $1.36 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account